• $5.1M
    Market Cap
  • -99.87%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
400,000
0.00%
400,000
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-5.1M
+49.62%
-3.4M
+3,653.33%
-90,000
N/A
N/A
N/A
Depreciation and Amortization Expense
1.4M
+14,300.00%
10,000
-97.91%
479,000
N/A
N/A
N/A
Total Operating Expenses
36.8M
+138.39%
15.4M
+193.03%
5.3M
+381.57%
1.1M
N/A
Operating Profit
-36.8M
+138.39%
-15.4M
+193.03%
-5.3M
+337.52%
-1.2M
N/A
Interest Income
2.2M
+16,823.08%
13,000
-13.33%
15,000
-99.24%
2.0M
N/A
Interest Expense
-319,000
-78.82%
-1.5M
+613.74%
-211,000
+111.00%
-100,000
N/A
Interest Income and Expense and Net
1.9M
+225.99%
-1.5M
+661.73%
-196,000
-110.45%
1.9M
N/A
Total Nonoperating Income and Expense
-2.5M
+3.52%
-2.4M
-150.41%
4.7M
+139.20%
2.0M
N/A
Income before Taxes
-36.8M
+138.39%
-15.4M
+193.03%
-5.3M
-780.28%
773,501
N/A
Income Taxes
N/A
N/A
-3.0M
-99.79%
-1.4B
-386,717.74%
374,862
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-39.7M
+122.79%
-17.8M
+3,226.92%
-535,000
-234.21%
398,639
N/A
Net Income from Continuing Operations Applicable to Common
-39.2M
+120.33%
-17.8M
+193.96%
-6.1M
-882.93%
773,501
N/A
Basic EPS and Net Income
-1,177.89
+5,637.41%
-20.53
+205,200.00%
-0.01
-116.67%
0.06
N/A
Diluted EPS and Net Income
-1,177.89
+5,637.41%
-20.53
+22,711.11%
-0.09
-250.00%
0.06
N/A
Basic Weighted Average Shares
33,300
-96.16%
867,096
-98.71%
67.0M
+322.17%
15.9M
N/A
Diluted Weighted Average Shares
33,300
-96.16%
867,096
-98.72%
67.9M
+327.97%
15.9M
N/A
Balance Sheet
Cash and Cash Equivalents
1.5M
+172.38%
554,000
-86.90%
4.2M
+1,122.75%
345,777
+612.13%
Short-Term Investments
N/A
N/A
4.2M
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
1.5M
-68.26%
4.8M
+12.44%
4.2M
+1,122.75%
345,777
+612.13%
Total Current Assets
4.4M
+61.29%
2.7M
-52.64%
5.7M
+786.58%
646,639
+520.80%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
269,000
+572.50%
40,000
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
269,000
+572.50%
40,000
N/A
N/A
N/A
136.9M
+2,856.98%
Total Assets
5.7M
+34.75%
4.2M
-41.96%
7.2M
-94.75%
137.5M
+64,424.49%
Income Taxes Payable
400,000
0.00%
400,000
+100.00%
200,000
-46.65%
374,862
N/A
Total Short-Term Debt
3.6M
+2,300.00%
150,000
-18.92%
185,000
N/A
N/A
N/A
Total Current Liabilities
12.8M
+19.36%
10.7M
+496.39%
1.8M
+330.89%
417,975
+117.12%
Total Long-Term Debt
2.1M
+162.50%
800,000
-48.95%
1.6M
N/A
N/A
N/A
Total Long-Term Liabilities
315,000
+28.57%
245,000
+72.54%
142,000
-99.39%
23.3M
N/A
Total Liabilities
12.8M
+16.69%
11.0M
+43.03%
7.7M
+52.20%
5.0M
+2,521.59%
Retained Earnings
-68.3M
+134.79%
-29.1M
+157.55%
-11.3M
+162.74%
-4.3M
+98,062.34%
Total Stockholders Equity
N/A
N/A
-6.8M
+1,386.43%
-457,000
-89.37%
-4.3M
-20,954.97%
Total Shares Outstanding
92,140
-93.35%
1.4M
-98.12%
73.8M
+1,718.35%
4.1M
+22.81%
Cash Flow
Cash from Operating Activities
-15.6M
+60.66%
-9.7M
+25.33%
-7.7M
+489.11%
-1.3M
N/A
Capital Expenditures
N/A
N/A
51,000
-96.81%
1.6M
N/A
N/A
N/A
Cash from Investing Activities
-808,000
+1,779.07%
-43,000
-105.93%
725,000
+100.54%
-134.9M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
17.4M
+187.16%
6.1M
-44.49%
10.9M
-91.99%
136.5M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-805.73%
+158.41%
-311.80%
+42,080.49%
-0.74%
-227.69%
0.58%
N/A
Return on Equity
N/A
N/A
491.01%
+2,082.95%
22.49%
+220.73%
-18.63%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.34
+35.13%
0.25
-92.06%
3.18
+105.75%
1.55
N/A
Cash Ratio
0.12
+128.10%
0.05
-97.80%
2.35
+183.77%
0.83
N/A
Debt-to-Equity Ratio
N/A
N/A
-0.14
-96.35%
-3.83
N/A
N/A
N/A
Debt-to-Assets Ratio
1.01
+345.19%
0.23
-6.56%
0.24
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow